NÖK THERAPEUTICS, INC. $10,000,000 CLASS “A” COMMON STOCK OFFERING AND SUBSCRIPTION AGREEMENTSubscription Agreement • December 9th, 2024 • Nok Therapeutics, Inc. • Pharmaceutical preparations • Florida
WHEREAS, Company is in the process of selling up to 5,000,000 (Five Million) shares (“Shares”) of Class “A” Common Stock to investors at the price of $2.00 (Two Dollars) per share;
NÖK THERAPEUTICS, INC. $10,000,000 CLASS “A” COMMON STOCK OFFERING AND SUBSCRIPTION AGREEMENTSubscription Agreement • November 26th, 2024 • Nok Therapeutics, Inc. • Pharmaceutical preparations • Florida
WHEREAS, Company is in the process of selling up to 5,000,000 (Five Million) shares (“Shares”) of Class “A” Common Stock to investors at the price of $2.00 (Two Dollars) per share;
Patent Confirmation AssignmentPatent Assignment • September 26th, 2024 • Nok Therapeutics, Inc.
Patent Transfer and Assignment Agreement between The bankruptcy estate of XNK Therapeutics AB (publ) and NÖK Therapeutics Inc. Dated 23 May 2024 Contents APPENDICESPatent Transfer and Assignment Agreement • September 26th, 2024 • Nok Therapeutics, Inc.
A On 9 April 2024, XNK Therapeutics AB (publ), a company incorporated and registered in Sweden with corporate registration number 556894-6601 (“XNK”), entered into bankruptcy (Sw. konkurs) and the district court appointed Anders Svensson Clark, lawyer (Sw. advokat), as the bankruptcy trustee (Sw. konkursförvaltare).
NÖK THERAPEUTICS, INC. $10,000,000 CLASS “A” COMMON STOCK OFFERING AND SUBSCRIPTION AGREEMENTSubscription Agreement • November 25th, 2024 • Nok Therapeutics, Inc. • Pharmaceutical preparations • Florida
WHEREAS, Company is in the process of selling up to 5,000,000 (Five Million) shares (“Shares”) of Class “A” Common Stock to investors at the price of $2.00 (Two Dollars) per share;
